Asia Consensus Delphi: Survey Three
Introduction
Thank you for your participation in this survey.
The scope of recommendations made by this committee is focused on the various applications of SIRT treatment with Y-90 resin microspheres for patients with conventionally incurable HCC in Asian countries where there is a high prevalence of hepatitis B and/or C.
The following “Strength of Recommendation” table has been provided to assist you in offering your recommendation for each of the statements in this survey. As you progress through the survey, you may click the thumbnail image below at any time, to view a high-resolution image of the table.
Please scroll down to begin the survey.